Jin Rong Jie·2025-08-01 12:49Group 1 - The core viewpoint of the article highlights the financial performance and market activity of Junshi Biosciences, indicating a recent decline in stock price and significant capital outflow [1][3] - As of August 1, 2025, Junshi Biosciences' stock closed at 38.08 yuan, down 0.99%, with a trading volume of 15.26 million shares and a transaction amount of 589 million yuan [1] - The latest quarterly report shows total revenue of 501 million yuan, a year-on-year increase of 31.46%, and a net profit attributable to shareholders of 234.88 million yuan, up 17.01% [1] Group 2 - The company has a current liquidity ratio of 1.398 and a quick ratio of 1.204, indicating a stable financial position [1] - Junshi Biosciences has invested in 41 companies and participated in 39 bidding projects, showcasing its active engagement in the industry [2] - The company holds 151 trademark registrations and 116 patents, along with 133 administrative licenses, reflecting its strong intellectual property portfolio [2]